查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676625

全球骨科生长因子市场：规模、占有率和趋势分析（2025-2031）：MedCore

Orthopedic Growth Factor Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Cervical Disc Degeneration Market, Tibial Fracture Market, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 40 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

估计2024年全球骨科生长因子市场规模将达到 10.5亿美元。预计该市场将以 2.2%的年复合成长率成长，到2031年达到 12亿美元。

由于取消了选择性手术，COVID-19 疫情导致2020年收入下降。儘管出现了暂时的中断，但预计到2022年市场将强劲復苏，恢復稳定成长。

脊椎融合仍是骨科生长因子成长的主要驱动力。进行的临床研究支持生长因子在骨融合和脊椎治疗中的有效性。该公司已获得FDA扩大适应症的批准，导致骨科生长因子的广泛应用。最近的批准刺激颈椎间盘疾病和后足/踝关节融合领域的发展。

本报告概述了全球骨科生长因子市场，包括市场分析和预测、驱动因素和限制因素以及竞争格局。

目录

执行摘要

  • 全球骨科生长因子市场概览
  • 竞争分析
  • 市场区隔
  • 目标区域

简介

工序数量

市场分析及预测

数位分析

  • 颈椎间盘退化生长因子
  • 胫骨骨折矫正术的生长因子
  • 脊椎骨科生长因子
  • 踝关节与后足融合生长因子

驱动因素与限制因素

竞争市场占有率分析

Product Code: iDATA_GLOB25_MC_GF

The global orthopedic growth factor market was valued at $1.05 billion in 2024 and is projected to grow at a CAGR of 2.2%, reaching $1.2 billion by 2031.

This market is segmented by indication type, including:

  • Cervical Disc Degeneration
  • Tibial Fractures
  • Spine
  • Ankle & Hindfoot Fusion

Market Insights & Data Coverage

  • Unit Sales & Average Selling Prices
  • Market Size & Growth Trends
  • Procedure Numbers
  • Market Drivers & Limiters
  • Market Forecasts Until 2031
  • Historical Data (2021-2023)
  • Competitive Landscape, Mergers & Acquisitions
  • Company Profiles & Product Portfolios

Market Trends

  • Impact of COVID-19 on Market Growth:

* The COVID-19 pandemic led to a decline in sales due to canceled elective surgeries in 2020.

* Despite this temporary disruption, the market recovered strongly by 2022 and returned to steady growth.

  • Continued Demand for Spinal Fusion Therapies:

* Spinal fusion remains a key driver of growth for orthopedic growth factors.

* Ongoing clinical research supports the efficacy of growth factors in bone healing and spinal procedures.

  • Regulatory Approvals Expanding Market Reach:

* Companies are securing FDA approvals for expanded indications, leading to wider adoption of orthopedic growth factors.

* Recent approvals have fueled growth in the cervical disc degeneration and hindfoot/ankle fusion segments.

Market Share Insights

Top Competitors in the Global Orthopedic Growth Factor Market (2024):

1 Medtronic

* Market leader in the orthopedic growth factor segment.

* INFUSE(R) remains the gold standard for spinal fusion therapies.

2 Cerapedics

* Second-largest market share with its i-Factor(TM) product.

* Expanded FDA approval allows i-Factor(TM) to be used in single-level anterior cervical discectomy fusion (ACDF) with an allograft bone ring or fusion interbody device.

3 Stryker

* Third-largest competitor, known for its AUGMENT(R) product line.

* AUGMENT(R) is the first and only FDA-approved alternative to autograft for hindfoot and ankle arthrodesis.

Market Segmentation Summary

Cervical Disc Degeneration Market

  • Growth factors aiding in cervical spine fusion procedures.

Tibial Fracture Market

  • Orthopedic growth factors used in tibial fracture repair and bone healing.

Spine Market

  • Key segment driven by spinal fusion procedures.

Ankle & Hindfoot Fusion Market

  • Focus on bone regeneration and fusion techniques for foot and ankle disorders.

Global Research Scope

  • Regions Covered:

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

  • Base Year: 2024
  • Forecast Period: 2025-2031
  • Historical Data: 2021-2023

Quantitative Coverage

  • Market Size, Market Shares
  • Market Forecasts, Growth Rates
  • Units Sold, Average Selling Prices
  • Procedure Numbers

Qualitative Coverage

  • COVID-19 Impact
  • Market Growth Trends & Limiters
  • Competitive Analysis & SWOT for Top Competitors
  • Mergers & Acquisitions
  • Company Profiles & Product Portfolios
  • FDA Recalls, Disruptive Technologies
  • Disease Overviews

Data Sources:

  • Primary Interviews with Industry Leaders
  • Government Physician Data & Regulatory Data
  • Hospital Private Data
  • Import & Export Data
  • iData Research Internal Database

TABLE OF CONTENT

  • 5.1 Executive Summary
    • 5.1.1 Global Orthopedic Growth Factor Market Overview
    • 5.1.2 Competitive Analysis
    • 5.1.3 Procedure Segmentation
    • 5.1.4 Market Segmentation
    • 5.1.5 Regions Included
  • 5.2 Introduction
  • 5.3 Procedure Numbers
  • 5.4 Market Analysis and Forecast
  • 5.5 Unit Analysis
    • 5.5.1 Cervical Disc Degeneration Growth Factor Units Sold
    • 5.5.1 Tibial Fracture Orthopedic Growth Factor Units Sold
    • 5.5.2 Spine Orthopedic Growth Factor Units Sold
    • 5.5.3 Ankle & Hindfoot Fusion Growth Factor Units Sold
  • 5.6 Drivers and Limiters
    • 5.6.1 Market Drivers
    • 5.6.2 Market Limiters
  • 5.7 Competitive Market Share Analysis

LIST OF CHARTS

  • Chart 5-1: Orthopedic Growth Factor Market, Global, 2024 & 2031
  • Chart 5-2: Orthopedic Growth Factor Procedures, Global, 2024
  • Chart 5-3: Orthopedic Growth Factor Procedures by Segment, Global, 2021 - 2031
  • Chart 5-4: Orthopedic Growth Factor Device Market, Global, 2021 - 2031
  • Chart 5-5: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024

LIST OF FIGURES

  • Figure 5-1: Orthopedic Growth Factor Procedure Segmentation
  • Figure 5-2: Orthopedic Growth Factor Market Segmentation
  • Figure 5-3: Orthopedic Growth Factor Regions Covered, Global (1 of 2)
  • Figure 5-4: Orthopedic Growth Factor Regions Covered, Global (2 of 2)
  • Figure 5-5: Orthopedic Growth Factor Procedures by Region, Global, 2024 - 2031
  • Figure 5-6: Orthopedic Growth Factor Procedures by Country, North America, 2021 - 2031
  • Figure 5-7: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 - 2031 (1 of 2)
  • Figure 5-8: Orthopedic Growth Factor Procedures by Country, Latin America, 2021 - 2031 (2 of 2)
  • Figure 5-9: Orthopedic Growth Factor Procedures by Country, Western Europe, 2021 - 2031
  • Figure 5-10: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 - 2031 (1 of 2)
  • Figure 5-11: Orthopedic Growth Factor Procedures by Country, Central & Eastern Europe, 2021 - 2031 (2 of 2)
  • Figure 5-12: Orthopedic Growth Factor Procedures by Country, Middle East, 2021 - 2031
  • Figure 5-13: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (1 of 3)
  • Figure 5-14: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (2 of 3)
  • Figure 5-15: Orthopedic Growth Factor Procedures by Country, Asia-Pacific, 2021 - 2031 (3 of 3)
  • Figure 5-16: Orthopedic Growth Factor Procedures by Country, Africa, 2021 - 2031
  • Figure 5-17: Orthopedic Growth Factor Market, Global, 2021 - 2031
  • Figure 5-18: Units Sold by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031
  • Figure 5-19: Average Selling Price by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031 (US$)
  • Figure 5-20: Market Value by Region, Orthopedic Growth Factor Market, Global, 2021 - 2031 (US$M)
  • Figure 5-21: Cervical Disc Degeneration Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-22: Tibial Fracture Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-23: Spine Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-24: Ankle & Hindfoot Fusion Growth Factor Units Sold by Region, Global, 2021 - 2031
  • Figure 5-25: Leading Competitors, Orthopedic Growth Factor Market, Global, 2024